CureAccelerator Live! is a philanthropic pitch event where up to 5 PIs pitch their clinical repurposing trial ideas. Attendees select the winning project which is awarded up to $50,000 in funding.
Read more about our 2020 CureAccelerator Live! philanthropic pitch events:
CureAccelerator Live! is an exciting philanthropic pitch event presented by Cures Within Reach that raises awareness of and funding for innovative repurposing research projects and gives attendees the chance to select and fund the next breakthrough treatment!
Principal Investigators are selected to pitch their clinical trials for repurposing medical treatments, and expert panelists representing academia, industry, clinicians and patients ask follow up questions. Then, attendees vote to award up to $50,000 in funding for the winning project, which is announced that evening.
CureAccelerator Live! is a unique networking opportunity for researchers, clinicians, patient groups, biomedical industry professionals and funders. It provides an opportunity to help harness the power of repurposing research and bring groundbreaking treatments to patients in need, while bringing key repurposing stakeholders together.
Sample CureAccelerator Live! Agenda:
Reception: 6 – 6:30 pm
Program, Pitches & Expert Q&A: 6:30 – 7:30 pm
Networking & Voting: 7:30 – 8 pm
Award & Close: 8 – 8:30 pm
CureAccelerator Live! To Date
CWR launched CureAccelerator Live! in 2016 with a Chicago focus. In 2017, CureAccelerator Live! for Oncology focused on clinical repurposing trials in unsolved cancers or unmet cancer needs. In 2018, CWR we held our first event outside of Chicago, focused on Mid-Atlantic research in October. In 2019, we held CureAccelerator Live! for the Developing World in Boston in May and for Rare Diseases in Philadelphia in June.
This successful, scalable program engages a variety of partners across the country to provide funds for academic researchers’ repurposing projects. Events may have several possible themes, including:
- Geographic (i.e. Chicago-based researchers / universities)
- Therapeutic or Patient Population (i.e. oncology, rare diseases or impacting veterans)
- Institutional (i.e. researchers from a specific partner institution)
- Researcher (i.e. any woman PI)